Jiangsu Bioperfectus Technologies Co., Ltd. (SHA:688399)

Market Cap	4.03B
Revenue (ttm)	350.10M
Net Income (ttm)	-29.25M
Shares Out	83.87M
EPS (ttm)	-0.30
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,227,715
Average Volume	898,499
Open	46.48
Previous Close	46.41
Day's Range	46.14 - 48.94
52-Week Range	38.73 - 71.05
Beta	0.59
RSI	42.93
Earnings Date	Aug 29, 2025

About SHA:688399

Jiangsu Bioperfectus Technologies Co., Ltd., a molecular diagnostic company, engages in the research, development, production, and sale of in vitro diagnostic products in China. It offers in vitro diagnostic reagents and supporting testing equipment, as well as in vitro testing services. The company was founded in 2010 and is headquartered in Taizhou, China.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2010
• Employees: 592
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688399

Financial Performance

In 2024, SHA:688399's revenue was 349.61 million, a decrease of -13.29% compared to the previous year's 403.18 million. Losses were -2.00 million, -99.46% less than in 2023.